Related Experiment Video
Updated: Apr 5, 2026

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
Published on: April 28, 2023
Wilson disease with hepatic presentation in an eight-month-old boy
Kuerbanjiang Abuduxikuer1, Li-Ting Li1, Yi-Ling Qiu1
1Kuerbanjiang Abuduxikuer, Li-Ting Li, Yi-Ling Qiu, Jian-She Wang, Liver Center, Children's Hospital of Fudan University, Shanghai 200032, China.
Insights
Wilson disease, a genetic copper metabolism disorder, can be fatal if untreated. This report details the youngest diagnosed patient, an 8-month-old Chinese boy, highlighting the need for early detection and treatment.
Area of Science:
- Genetics
- Metabolic Disorders
- Pediatrics
Background:
- Wilson disease is an inherited autosomal recessive disorder affecting copper metabolism.
- Untreated Wilson disease can lead to severe neurological and hepatic complications.
- Early diagnosis and intervention are crucial for managing Wilson disease.
Observation:
- An 8-month-old Chinese boy presented with elevated liver enzymes and low serum ceruloplasmin.
- Genetic analysis identified two heterozygous mutations in the ATP7B gene (c.2621C>T/p.A874V and c.3809A>G/p.N1270S).
- This case represents the youngest reported patient with elevated liver enzymes due to Wilson disease.
Findings:
- The patient's persistent elevation of serum aminotransferase normalized after zinc therapy.
- Genetic testing confirmed compound heterozygous mutations in the ATP7B gene.
- Parental origin of the mutations was established.
Implications:
- This case underscores the importance of early Wilson disease diagnosis in infants presenting with liver enzyme abnormalities.
- Increased pediatrician awareness can lead to timely diagnosis and treatment, improving patient outcomes.
- Zinc therapy demonstrated efficacy in normalizing liver enzymes in this young patient.
Abstract:
Wilson disease is an autosomal recessive disorder of copper metabolism that can cause fatal neurological and hepatic disease if not diagnosed and treated. The youngest child with normal liver function reported so far is an 8-mo-old Japanese boy with low ceruloplasmin levels, and the youngest child with elevated aminotransferase ever reported so far is a 9-mo-old Korean boy with confirmed by genetic testing. Here we report an 8-mo-old Chinese boy presented with elevated liver enzymes, and low serum ceruloplasmin level. Genetic analysis of ATP7B gene detected two heterozygous disease causing mutations (c.2621C>T/p.A874V and c.3809A>G/p.N1270S), and parental origins were determined. Persistent elevation of serum aminotransferase in this infant was normalized after zinc therapy. To our best knowledge, this is the youngest patient with elevated liver enzymes ever reported worldwide. We hope that this will raise awareness among pediatricians, leading to earlier diagnosis, timely treatment, and better clinical outcome.
More Related Videos
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Lysosomal Hydrolases

